Home
>
National Drug Code (NDC)
>
Zyprexa
Zyprexa - 0002-4116-33 - (Olanzapine)
Drug Information of Zyprexa
| Product NDC: | 0002-4116 |
| Proprietary Name: | Zyprexa |
| Non Proprietary Name: | Olanzapine |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; Olanzapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zyprexa
| Product NDC: | 0002-4116 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020592 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19961001 |
Package Information of Zyprexa
| Package NDC: | 0002-4116-33 |
| Package Description: | 100 BLISTER PACK in 1 CARTON (0002-4116-33) > 1 TABLET in 1 BLISTER PACK (0002-4116-01) |
NDC Information of Zyprexa
| NDC Code | 0002-4116-33 |
| Proprietary Name | Zyprexa |
| Package Description | 100 BLISTER PACK in 1 CARTON (0002-4116-33) > 1 TABLET in 1 BLISTER PACK (0002-4116-01) |
| Product NDC | 0002-4116 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Olanzapine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19961001 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | OLANZAPINE |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
